The first in vivo evidence for the anti-inflammatory potential of VAP-1 inhibition was obtained when anti-VAP-1 antibodies were found to decrease leukocyte infiltration by about 70% in an acute model of peritonitis in rabbits (128). This evidence concerns the gene AOC3 and peritonitis.